KKS-NETZWERK EV -NETZWERK DER KOORDINIERUNGSZENTREN FUR KLINISCHE STUDIEN

Their core work

KKS-Netzwerk is Germany's national network of coordinating centres for clinical trials, providing methodological and operational support for investigator-initiated clinical studies. They contribute clinical trial design, regulatory expertise, data management, and quality assurance to multinational health research projects. Their involvement spans therapeutic areas from cardiovascular and neurological conditions to ophthalmology and inflammatory disorders, always in the role of enabling rigorous, multi-centre trial execution. Essentially, they are the infrastructure backbone that makes large-scale European clinical trials run properly.

What they specialise in

How they've shifted over time

In their earlier H2020 projects (2015-2017), KKS-Netzwerk focused on classical interventional clinical trials — testing specific drugs or surgical techniques for conditions like cardiac hypertrophy, spinal cord injury, and aortic aneurysm repair. From 2017 onward, the focus shifted markedly toward clinical endpoint innovation: validating new outcome measures, developing digital biomarkers for fatigue and sleep, and integrating patient-reported outcomes into trial design. Their participation in EOSC-Life signals a further expansion into research data infrastructure and open science compliance — moving from just running trials to shaping how trial data is managed and shared across Europe.

Moving from traditional trial execution toward digital endpoint development and research data infrastructure, positioning them for next-generation decentralized clinical trials.

How they like to work

KKS-Netzwerk operates exclusively as a third-party contributor — they have never coordinated or directly participated as a named partner in their H2020 projects, instead being brought in by consortium members who need their clinical trial coordination expertise. With 209 unique partners across 23 countries, they work in large, diverse consortia typical of major European clinical research initiatives. This pattern suggests they function as a trusted service provider that consortia tap into for specific methodological and regulatory capabilities rather than as a strategic research partner driving scientific direction.

Connected to 209 unique consortium partners across 23 countries, reflecting the large multi-centre trial consortia they support. Their network is pan-European with no narrow geographic clustering, consistent with their role enabling continent-wide clinical studies.

What sets them apart

KKS-Netzwerk occupies a rare niche as a national-level clinical trial support network — not a single university or hospital, but a coordinated system of trial centres across Germany. This gives them the ability to mobilize patient recruitment, regulatory compliance, and data management at scale across multiple German sites simultaneously. For any consortium needing robust German clinical trial infrastructure without negotiating with individual hospitals, they are the single point of contact.

Highlights from their portfolio

• IDEA-FAST
  Longest-running project (2019-2026) focused on digital endpoints for neurodegenerative and inflammatory disorders — represents their most forward-looking work in digital health measurement.
• TENSION
  Landmark stroke thrombectomy trial testing extended time windows, with direct impact on clinical guidelines for acute stroke treatment across Europe.
• EOSC-Life
  Their only non-clinical project, connecting them to the European Open Science Cloud infrastructure — signals strategic expansion beyond trial execution into research data management.